Role of Virechana Karma in the management of uterine fibroid along with Metrorrhagia- A Case Study

  • Surangi Sajeewane Perera 2nd year MS scholar, Department of Prasooti Tantra and StreeRoga (PTSR), IPGT&RA, Gujarat Ayurved University, Jamnagar
  • Laxmi Priya Dei Dean, HOD, and Professor Department of Prasuti Tantra and StreeRoga, IPGT&RA, Gujarat Ayurved University, Jamnagar
Keywords: Ayurveda, Basti, Mamsaja granthi, Samshodhana karma, Uterine fibroid, Virechana.


A uterine fibroid is the most common, non-cancerous tumor in women of childbearing age and the second most common reason women of childbearing age undergo surgery. Metrorrhagiais one of the most common menstrual disorder associated with uterine fibroid and it is caused to excessive menstrual bleeding with or without intermenstrual bleeding. In Ayurveda, texts have described mamsajagranthi which perfectly correlates with benign neoplasm on modern lines. Here the study was undertaken to evaluate the effect of virechanakarmafor uterine fibroid with mild adenomyosis and other complications. 36 years old female multigravida patient, was diagnosed with uterine fibroid on the basis of clinical features and USG findings. This study was planned to find out Ayurvedic management of Uterine fibroid with samshodhanakarma. Therefore, after taking written informed consent patient was treated with virechanakarma with Trivrutavaleha with Thripalakwatha. The result of this study was found after this therapy, all major complaints like irregular excessive menstrual bleeding, the lower-abdominal pain completely reduced, and weight also got reduced and also reduced the size of the fibroid in vertically as well as horizontally. It can be concluded that uterine fibroid can be efficiently and effectively managed with Virechana Karma and the complication be prevented.

How to Cite
Perera, S., & Dei, L. P. (2018, September 29). Role of Virechana Karma in the management of uterine fibroid along with Metrorrhagia- A Case Study. International Journal of AYUSH Case Reports, 2(3), 45-50.
Case Reports